NCT00955292 2009-08-10Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or LymphomasCylene PharmaceuticalsPhase 1 Terminated12 enrolled
NCT00955786 2009-08-10Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or LymphomasCylene PharmaceuticalsPhase 1 Completed48 enrolled
NCT00485966 2008-11-05Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic LeukemiaCylene PharmaceuticalsPhase 2 Withdrawn25 enrolled